Dornase Alpha, also known by its brand name Pulmozyme, is a medication used in the treatment of cystic fibrosis. This drug is a recombinant human deoxyribonuclease enzyme that works by breaking down the thick, sticky mucus that can build up in the lungs of individuals with cystic fibrosis. By thinning the mucus, Dornase Alpha helps to improve lung function and reduce the risk of respiratory infections.

Patients with cystic fibrosis often have difficulty clearing mucus from their lungs, which can lead to breathing difficulties and an increased risk of lung infections. Dornase Alpha is an important tool in managing these symptoms and improving quality of life for individuals with cystic fibrosis.

It is important to use Dornase Alpha as prescribed by your healthcare provider. This medication is typically administered through a nebulizer, which allows the medication to be inhaled directly into the lungs. Your healthcare provider will provide instructions on how to properly use the nebulizer and administer the medication.

Like all medications, Dornase Alpha may cause side effects in some individuals. Common side effects may include voice changes, sore throat, and chest pain. If you experience any severe or persistent side effects, it is important to contact your healthcare provider.

Overall, Dornase Alpha is an important medication in the treatment of cystic fibrosis. By helping to thin mucus in the lungs, this medication can improve lung function and quality of life for individuals with this condition. If you have any questions or concerns about Dornase Alpha, be sure to discuss them with your healthcare provider.